SIK2 and neoplasm: E-TABM RNA sequencing dataset [40] showed a statistically significant reduction of SIK2 expression in advanced stage of breast tumors (n=19, stage 3-4) as compared to early tumor stages (n=26; stage 1; Figure 1B).